Among patients with IBD, prophylactic use of heparin (vs no use) was associated with a lower rate of VTE without increasing bleeding risk. ow.ly/Whac50QML0j #thrombosisandhemostasis

The @RPTHJournal Research Recap is happening TOMORROW! Watch live as experts discuss: ⚖️⚖️Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: A decision analysis ⚖️⚖️ Register here: streamyard.com/watch/XqV7APR7…

Having benefited from excellent mentors over the course of her career, a physician concludes that a true mentor is someone who has more imagination about you than you have about yourself. Read the full Perspective: nej.md/3SDFcPf

Is your passion for writing as strong as your love for hematology? This could be you at #ASH24! Apply to be an author for the official publication of the ASH annual meeting by🚨April 12! 🚨ow.ly/moP850R5YWC

If you are attending #THSNA2024 THSNA, make sure to check our late-breaking abstract in our response to American Geriatrics Society updated Beers Criteria on the use of #rivaroxaban in older adults with non-valvular #afb vs #apixaban #warfarin #dabigatran #anticoagulants

Wonderful collaboration between @VUMC_Medicine with Adam Cuker MD, MS Penn Medicine

👢 Boot Camp in Nashville is coming up soon! Join us in-person May 17-18 & earn ~13 CE credits. Learn w/ @aburnett_PharmD, Geoff Barnes & more. Plus, enjoy FREE golf cart shuttle service to explore the vibrant Broadway scene! Don't miss out, register now! bit.ly/3vXac57

Congrats Staci! Well-deserved!

Grateful for AAUW to have the opportunity to inspire the next generation of minority women #Science #WomenPower #woman #AcademicTwitter @VUMC_Insights @VUMC_Medicine Vanderbilt University Medical Center #MiddleEast #EducationMatters U.S. Embassy Jordan EducationUSA

Nominations are open for the VanderbiltPostdoctoralAssociation 2024-2025 VPA Executive Board. The Executive Board helps to promote scholarly learning, social activities, and postdoc advocacy. Self-nominations are welcomed and encouraged! Please submit by May 34 at redcap.link/hw359xse

Read our response to Beers criteria by American Geriatrics Society regarding #rivaroxaban in older adults, a wonderful collaboration @VUMC_Medicine & Adam Cuker MD, MS Penn Medicine sciencedirect.com/science/articl… #anticoagulation Anticoagulation Forum JTH #AF Vanderbilt University Medical Center @VUMCResearch @VUMC_Insights

Are you feeling revitalized? 🎇 #ASH24 has been an incredible reminder of why we do what we do. The knowledge and inspiration gained here will undoubtedly lead to exciting advances as we return home to apply what we've learned. Here's to a fantastic final day in San Diego!

Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above

Our work evaluating #anticoagulants #DOAC in #AF & #VHD is out JAHA #AHA journal, wonderful collaboration with James Lewis Adam Cuker MD, MS #vanderbilt Penn Medicine Vanderbilt University Medical Center Vanderbilt School of Medicine accompanying editorial to follow ahajournals.org/doi/10.1161/JA…

Read wonderful well-written #editorial published with our article JAHA by Ana Catarina Fonseca, MD PhD MPH Claudia Jorge #AHA reflecting on our work on ##anticoagulants #DOACs in #AF & #VHD Adam Cuker MD, MS James Lewis Vanderbilt School of Medicine Penn Medicine ahajournals.org/doi/10.1161/JA…

Study evaluates the conventional and distributional cost-effectiveness of prophylaxis with efanesoctocog alfa versus standard-care factor VIII (standard half-life and extended half-life) for patients living with severe hemophilia A in the United States. Read more at